Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Plasma 25,OH Vitamin D Concentrations Are Not Associated with Rheumatoid Arthritis (RA)-related Autoantibodies in Individuals at Elevated Risk for RA

MARIE FESER, LEZLIE A. DERBER, KEVIN D. DEANE, DENNIS C. LEZOTTE, MICHAEL H. WEISMAN, JANE H. BUCKNER, TED MIKULS, JAMES O’DELL, PETER K. GREGERSEN, V. MICHAEL HOLERS and JILL M. NORRIS
The Journal of Rheumatology May 2009, 36 (5) 943-946; DOI: https://doi.org/10.3899/jrheum.080764
MARIE FESER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LEZLIE A. DERBER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEVIN D. DEANE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DENNIS C. LEZOTTE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAEL H. WEISMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JANE H. BUCKNER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TED MIKULS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAMES O’DELL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER K. GREGERSEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. MICHAEL HOLERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JILL M. NORRIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jill.Norris@ucdenver.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective. To evaluate the association between rheumatoid arthritis (RA)-related autoantibodies and plasma 25,OH vitamin D in subjects at risk for RA.

Methods. In 1210 subjects without RA, 76 were positive for anti-cyclic citrullinated peptide antibodies or for at least 2 rheumatoid factors (RF; by nephelometry: RF-IgM, RF-IgG, RF-IgA). 25,OH vitamin D was measured in these cases and 154 autoantibody-negative controls from this cohort.

Results. 25,OH vitamin D levels did not differ between cases and controls (adjusted OR 1.23, 95% CI 0.93–1.63).

Conclusion. Vitamin D concentrations are not associated with RA-related autoimmunity in unaffected subjects at increased risk for RA.

  • VITAMIN D
  • RHEUMATOID ARTHRITIS
  • AUTOANTIBODIES

Footnotes

  • Supported by the National Institutes of Health Autoimmunity Prevention Center grants U-19 AI050864, R-01AR051394; grants MO1 RR00069, MO1 RR00425, General Clinical Research Centers Program, National Center for Research Resources, NIH; and a Research Support Fund grant from the Nebraska Medical Center and the University of Nebraska Medical Center.

    • Accepted for publication November 10, 2008.
View Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 5
1 May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Plasma 25,OH Vitamin D Concentrations Are Not Associated with Rheumatoid Arthritis (RA)-related Autoantibodies in Individuals at Elevated Risk for RA
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Plasma 25,OH Vitamin D Concentrations Are Not Associated with Rheumatoid Arthritis (RA)-related Autoantibodies in Individuals at Elevated Risk for RA
MARIE FESER, LEZLIE A. DERBER, KEVIN D. DEANE, DENNIS C. LEZOTTE, MICHAEL H. WEISMAN, JANE H. BUCKNER, TED MIKULS, JAMES O’DELL, PETER K. GREGERSEN, V. MICHAEL HOLERS, JILL M. NORRIS
The Journal of Rheumatology May 2009, 36 (5) 943-946; DOI: 10.3899/jrheum.080764

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Plasma 25,OH Vitamin D Concentrations Are Not Associated with Rheumatoid Arthritis (RA)-related Autoantibodies in Individuals at Elevated Risk for RA
MARIE FESER, LEZLIE A. DERBER, KEVIN D. DEANE, DENNIS C. LEZOTTE, MICHAEL H. WEISMAN, JANE H. BUCKNER, TED MIKULS, JAMES O’DELL, PETER K. GREGERSEN, V. MICHAEL HOLERS, JILL M. NORRIS
The Journal of Rheumatology May 2009, 36 (5) 943-946; DOI: 10.3899/jrheum.080764
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Do Patterns of Early Disease Severity Predict Grade 12 Academic Achievement in Youths With Childhood-Onset Chronic Rheumatic Diseases?
  • High Prevalence of Foot Insufficiency Fractures in Patients With Inflammatory Rheumatic Musculoskeletal Diseases
  • Real-world Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire